Crossmark

Mode of action and resistance studies unveil new roles for tropodithietic acid as an anticancer agent and the γ-glutamyl cycle as a proton sink

Crossref DOI link: https://doi.org/10.1073/pnas.1518034113

Published Online: 2016-01-22

Published Print: 2016-02-09

Update policy: https://doi.org/10.1073/pnas.cm10313

Authors

Wilson, Maxwell Z.

Wang, Rurun

Gitai, Zemer

Seyedsayamdost, Mohammad R.
Funding

Funding for this research was provided by:

HHS | NIH | National Institute of General Medical Sciences (GM098299)

HHS | NIH | NIH Office of the Director (1DP2OD004389)
License Information

Version of Record valid from 2016-07-22
More Information

Publication History

Published: 2016-01-22